"10.1371_journal.pone.0038451","plos one","2012-06-06T00:00:00Z","Uffe Vest Schneider; Nikolaj Dam Mikkelsen; Anja Lindqvist; Limei Meng Okkels; Nina JÃ¸hnk; Gorm Lisby","QuantiBact A/S, Hvidovre, Denmark","Conceived and designed the experiments: UVS NDM AL LMO NJ GL. Performed the experiments: UVS NDM AL LMO NJ. Analyzed the data: UVS NDM AL GL. Wrote the paper: UVS GL.","The authors have the following interest. All authors are employees of QuantiBact A/S, which has exclusive license to use TINA modified oligonucleotides for human diagnostics and WO 2009/112032 A1 owned by QuantiBact A/S covers use of TINA molecules for commercial PCR assays. QuantiBact A/S seeks to make the use and design of TINA modified oligonucleotides known broadly within the scientific community. There are no further patents or products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","06","Uffe Vest Schneider","UVS",6,TRUE,6,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
